---
$id: https://graph.org.ai/products/commodity/51111871
$type: Product
source: UNSPSC
code: "51111871"
title: "Vorozole"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vorozole

**UNSPSC Code**: 51111871
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a non-steroidal aromatase inhibitor with the molecular formula C16H13ClN6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1E2S9YXV2A, chemically known as 6-((4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzotriazole,d- but generally known as vorozole, which bears US NIH Compound Identifier 60796. European Medicines Agency schedules Vorozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00088MIG. The term VOROZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). World Health Organization schedules vorozole in its Anatomical Therapeutic Chemical (ATC) Classification. VOROZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vorozole under HS 29339990 and SITC 51577. As of Q4 2014, VOROZOLE remains the US FDA Preferred Term for this commodity. Vorozole bears US NLM identifiers UMLS ID C0286224 and NCI Concept Code C1601. SMILES: CLC1CCC(C(N2NCNC2)C2CC3N(NNC3CC2)C)CC1.

